tirzepatide target (Mounjaro) In Sherman Oaks FDA Grants Tirzepatide a New

GHK-Cu (Copper Tripeptide-1) 50mg total per bottle 625 mcg 80 sprays/bottle 10mL bottle 99.876% purity 99.876% purity (HPLC) Third-party tested Freedom Diagnostics Identity confirmed Certificate of Analysis Tested by Freedom Diagnostics 04/12/2026 Key Ingredients Tripeptide-copper complex studied for its ability to modulate over 4,000 human genes

The warning states that Mounjaro has caused thyroid tumors in animal studies

Drowsiness is the most commonly reported side effect in studies, occurring in up to 38% (38 out of 100) of people

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

Are you pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed